News Releases


30 March 2020
Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids








News Releases

30 March 2020
Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids
17 March 2020
TORONTO , March 17, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced today that the Company determined, on the recommendation of the Audit Committee of the Company’s Board of Directors and after consultation with KPMG LLP , the
02 March 2020
TORONTO , March 02, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission , providing the Company a 15-day extension of the due date for filing its
07 January 2020
TORONTO , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the ICR Conference 2020 on January 14, 2020 at 9:00 a.m.